Paid Clinical Trials in Delaware

Delaware has 268 paid clinical trials enrolling now across cities including Newark, Wilmington and Rehoboth Beach. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 14, 2026.

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

252 clinical trials

Get a weekly email when new trials open in Newark, DE.

Non-Invasive Preeclampsia Screening and Biobank

for Preeclampsia (PE)

Sites in Newark +19 more locations

Sponsor: Sequenom, Inc.

Sex: Female·Age: 18+·Accepts healthy volunteers

Code: NCT06643741·Recruiting·Listed Oct 2024

Apply to this trial

Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System

for Focal Segmental Glomerulosclerosis

Sites in Wilmington +9 more locations

Sponsor: Kaneka Medical America LLC

Sex: All·Age: Up to 75

Code: NCT04065438·Recruiting·Listed Aug 2019

Apply to this trial

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

for Focal Segmental Glomerulosclerosis

Drug: Sparsentan

Sites in Wilmington +16 more locations

Sponsor: Travere Therapeutics, Inc.

Sex: All·Age: 1 - 17

Code: NCT05003986·Phase 2·Recruiting·Listed Aug 2021

Apply to this trial

Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.

for Infertility (IVF Patients)

Sites in Newark +15 more locations

Sponsor: Granata Bio Corporation

Sex: Female·Age: 18 - 42

Code: NCT07216742·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

Study of SGR-1505 in Mature B-Cell Neoplasms

for Mature B-Cell Neoplasm

Sites in Newark +15 more locations

Sponsor: Schrödinger, Inc.

Sex: All·Age: 18+

Code: NCT05544019·Phase 1·Recruiting·Listed Sep 2022

Apply to this trial

Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors

for Advanced Cancer

Drug: RBS2418

Sites in Newark +11 more locations

Sponsor: Riboscience, LLC.

Sex: All·Age: 18+

Code: NCT05270213·Phase 1·Recruiting·Listed Mar 2022

Apply to this trial

A Multicenter Multinational Observational Study of Children With Hypochondroplasia

for Hypochondroplasia

Sites in Wilmington +15 more locations

Sponsor: BioMarin Pharmaceutical

Sex: All·Age: Up to 15

Code: NCT06212947·Recruiting·Listed Jan 2024

Apply to this trial

Deep Neural Network Stratification for Use Detecting Endometriosis in Women Affected by Chronic Pelvic Pain (EndoCheck)

for Endometriosis

Sites in Newark +9 more locations

Sponsor: Aspira Women's Health

Sex: Female·Age: 14 - 50

Code: NCT05245695·Recruiting·Listed Feb 2022

Apply to this trial

A Study to Evaluate a New Semi-rigid Brace, the RESILIENT Brace by Thinks Works, as a Way to Limit Curve Worsening in Kids With Idiopathic Scoliosis.

for Idiopathic Scoliosis

1 location in Wilmington

Sponsor: Thinks Works, PBC

Sex: All·Age: 9 - 16

Code: NCT07574632·Recruiting·Listed May 2026

Apply to this trial

Study to Evaluate the Efficacy and Safety of BMN 333 Versus Vosoritide in Children With Achondroplasia

for Achondroplasia

Drug: Vosoritide

Sites in Wilmington +8 more locations

Sponsor: BioMarin Pharmaceutical

Sex: All·Age: 2 - 17

Code: NCT07441876·Phase 2, Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of Age

for Catheter-Related Infections

Sites in Wilmington +5 more locations

Sponsor: CorMedix Therapeutics

Sex: All·Age: Up to 17

Code: NCT06714864·Phase 4·Recruiting·Listed Dec 2024

Apply to this trial

Osteogenesis Imperfecta Trial of AGA2115 for ADUlts With COL1A1 and/or COL1A2 GeNetic Variations (IDUN)

for Osteogenesis Imperfecta (OI)

Sites in Wilmington +8 more locations

Sponsor: Angitia Incorporated Limited

Sex: All·Age: 18 - 75

Code: NCT07062588·Phase 2·Recruiting·Listed Jul 2025

Apply to this trial

An External Control Arm Study in Non-Small Cell Lung Cancer

for Non Small Cell Lung Cancer

Sites in Dover, Milford +6 more locations

Sponsor: N-Power Medicine

Sex: All·Age: 18+

Code: NCT07174388·Recruiting·Listed Sep 2025

Apply to this trial

A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)

for Heterozygous Familial Hypercholesterolemia (HeFH)

Drug: Enlicitide Decanoate

Sites in Wilmington +6 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 6 - 17

Code: NCT07058077·Phase 2, Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

Tezspire Cardiac Events PASS

for Cardiovascular Events

1 location in Wilmington

Sponsor: AstraZeneca

Sex: All·Age: 12 - 130

Code: NCT06951867·Recruiting·Listed Apr 2025

Apply to this trial

FastWire REvascularisation of Extremities, (For LOWer Limbs) - FREEFLOW

for Chronic Total Occlusion of Artery of the Extremities

Sites in Wilmington +5 more locations

Sponsor: Versono Medical Ltd

Sex: All·Age: 18 - 85

Code: NCT06492733·Recruiting·Listed Jul 2024

Apply to this trial

Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer

for Non Small Cell Lung Cancer

Sites in Dover, Milford +7 more locations

Sponsor: N-Power Medicine

Sex: All·Age: 18+

Code: NCT07028489·Recruiting·Listed Jun 2025

Apply to this trial

Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver Impairment

for Advanced or Metastatic Solid Tumor

Sites in Newark +5 more locations

Sponsor: Gilead Sciences

Sex: All·Age: 18+

Code: NCT04617522·Phase 1·Recruiting·Listed Nov 2020

Apply to this trial

A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors

for Solid Tumor

Sites in Newark +8 more locations

Sponsor: Sanofi

Sex: All·Age: 18+

Code: NCT05584670·Phase 1, Phase 2·Recruiting·Listed Oct 2022

Apply to this trial

A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT)

for Cytomegalovirus (CMV)

Sites in Wilmington +7 more locations

Sponsor: Takeda

Sex: All·Age: Up to 17

Code: NCT05319353·Phase 3·Recruiting·Listed Apr 2022

Apply to this trial

Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Colorectal Cancer

for Metastatic Colorectal Cancer

Drug: RBS2418

Sites in Newark +1 more location

Sponsor: Riboscience, LLC.

Sex: All·Age: 18+

Code: NCT06824064·Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia

for Relapsed/Refractory Acute Myeloid Leukemia

Sites in Newark +5 more locations

Sponsor: Nerviano Medical Sciences

Sex: All·Age: 18+

Code: NCT06549790·Phase 1·Recruiting·Listed Aug 2024

Apply to this trial

A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data

for Cancer

Sites in Dover, Milford +5 more locations

Sponsor: N-Power Medicine

Sex: All·Age: 18 - 120·Accepts healthy volunteers

Code: NCT06877884·Recruiting·Listed Mar 2025

Apply to this trial

Development and Validation of a Novel Eye-Tracking Software-based Platform to Extract Oculometric Measures

for Eye Movement

1 location in Wilmington

Sponsor: NeuraLight

Sex: All·Age: 18 - 90

Code: NCT05476523·Recruiting·Listed Jul 2022

Apply to this trial

Autologous Adipose Cells Therapy

for Hair Loss/Baldness

Sites in Newark & Lewes

Sponsor: CERM INC.

Sex: All·Age: 21 - 80

Code: NCT06869252·Phase 1, Phase 2·Recruiting·Listed Mar 2025

Apply to this trial

A Clinical Trial on the Use of Lidocaine Infusion During Surgery for Pediatric Upper Extremity Fractures and Its Impact on Total Perioperative Opioid Requirements

for Fracture Arm

1 location in Wilmington

Sponsor: Nemours Children's Clinic

Sex: All·Age: 3 - 18

Code: NCT07552766·Phase 4·Recruiting·Listed Apr 2026

Apply to this trial

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

for Anatomic Stage II Breast Cancer AJCC v8

Drug: Ribociclib

Sites in Newark, Rehoboth Beach +171 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT07391774·Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

Quality of End-of-Life Care for Children With Cancer

for Childhood Hematopoietic and Lymphatic System Neoplasm

Sites in Wilmington +27 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT07412002·Recruiting·Listed Feb 2026

Apply to this trial

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

for Lung Non-Small Cell Carcinoma

Drug: Atezolizumab

Sites in Newark, Rehoboth Beach +61 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT07388524·Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

for Chronic Lymphocytic Leukemia

Drug: Sonrotoclax

Sites in Newark +205 more locations

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All·Age: 65+

Code: NCT07321652·Phase 3·Recruiting·Listed Jan 2026

Apply to this trial

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

for Ampulla of Vater Carcinoma

Sites in Newark, Wilmington +346 more locations

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT07283939·Recruiting·Listed Dec 2025

Apply to this trial

Breathing Patterns in Infants Before and After Extubation

for Respiratory Distress Syndrome (RDS)

1 location in Newark

Sponsor: Christiana Care Health Services

Sex: All·Age: 0 Days - 6 Months·Accepts healthy volunteers

Code: NCT07542301·Recruiting·Listed Apr 2026

Apply to this trial

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

for Breast Cancer

Sites in Newark, Wilmington +1087 more locations

Sponsor: NRG Oncology

Sex: Female·Age: 18 - 60

Code: NCT05879926·Phase 3·Recruiting·Listed May 2023

Apply to this trial

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

for Lung Non-Small Cell Carcinoma

Sites in Newark, Rehoboth Beach +625 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT04267848·Phase 3·Recruiting·Listed Feb 2020

Apply to this trial

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

for Advanced Endometrial Carcinoma

Drug: Bevacizumab

Sites in Newark, Rehoboth Beach +261 more locations

Sponsor: National Cancer Institute (NCI)

Sex: Female·Age: 18+

Code: NCT07198074·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

for Stage III Colon Cancer

Sites in Newark +924 more locations

Sponsor: NRG Oncology

Sex: All·Age: 18+

Code: NCT05174169·Phase 2, Phase 3·Recruiting·Listed Dec 2021

Apply to this trial

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

for Advanced Esophageal Adenocarcinoma

Drug: Nivolumab

Sites in Newark, Wilmington +626 more locations

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All·Age: 18+

Code: NCT05677490·Phase 3·Recruiting·Listed Jan 2023

Apply to this trial

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

for Anatomic Stage I Breast Cancer AJCC v8

Sites in Newark, Rehoboth Beach +594 more locations

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All·Age: 18+

Code: NCT06876714·Phase 3·Recruiting·Listed Mar 2025

Apply to this trial

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

for Astrocytoma, IDH-Mutant, Grade 3

Drug: Vorasidenib

Sites in Newark +116 more locations

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All·Age: 12+

Code: NCT07215910·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

for Chronic Lymphocytic Leukemia

Sites in Newark, Rehoboth Beach +294 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT04269902·Phase 3·Recruiting·Listed Feb 2020

Apply to this trial